Harmony Biosciences Holdings, Inc. (HRMY)
27.71
-0.03
(-0.11%)
USD |
NASDAQ |
Apr 06, 16:00
27.80
+0.09
(+0.32%)
After-Hours: 20:00
Harmony Biosciences Holdings SG&A Expense (TTM) : 272.05M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Castle Biosciences, Inc. | 229.32M |
| BioMarin Pharmaceutical, Inc. | 1.153B |
| Amicus Therapeutics, Inc. | 383.49M |
| Iovance Biotherapeutics, Inc. | 152.58M |
| Apellis Pharmaceuticals, Inc. | 550.26M |